Global Bifurcation Lesions Market Report 2024

Bifurcation Lesions Global Market Report 2024 – By Types (One-Stent, Two-Stent), By Application (Coronary Vascular, Peripheral Vascular) – Market Size, Trends, And Global Forecast 2024-2033

Bifurcation Lesions Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 200 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Bifurcation Lesions Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN

Bifurcation Lesions Market Definition

Bifurcation lesions refer to a coronary artery constriction that occurs next to or involves the origin of a vital side branch one does not want to lose. It occurs when plaque deposits accumulate, and the artery becomes too small for adequate blood flow to your heart.

The main types of bifurcation lesions are one-stent and two-stent. One-stent bifurcation lesions refer to a procedure where the side branch is provisionally stented if the intervention is required owing to clinical complaints, angiographic results, or other adjunctive variables. The main branch is stented first in this approach. The bifurcation angle is determined by the internal angle between the main and side branches. These types of bifurcation lesions are applied in coronary and peripheral vascular.

Bifurcation Lesions Market Segmentation

The bifurcation lesions market covered in this report is segmented –

1) By Types: One-Stent, Two-Stent

2) By Application: Coronary Vascular, Peripheral Vascular

Global Bifurcation Lesions  Market Size 2023 to 2028: Graph

Bifurcation Lesions Market Size 2024 And Growth Rate

The bifurcation lesions market size has grown strongly in recent years. It will grow from $2.47 billion in 2023 to $2.7 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rise in prevalence of coronary artery diseases, rise in geriatric population, rise in healthcare expenditure, economic growth.

Bifurcation Lesions Market Growth Forecast

The bifurcation lesions market size is expected to see strong growth in the next few years. It will grow to $3.74 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing demand for minimally invasive surgeries, expansion of healthcare infrastructure and facilities, increasing prevalence of cardiovascular diseases, government healthcare policies. Major trends in the forecast period include patient-centric approaches, bioresorbable stents, integration of ai and machine learning, cross-specialty collaboration.

Bifurcation Lesions Market Driver: Rising Geriatric Population Fuels Growth In The Bifurcation Lesions Market

The increase in geriatric population is expected to drive the growth of the bifurcation lesions market. People whose age is more than 60 years are more likely to suffer a heart attack, a stroke, or develop coronary heart disease and heart failure than younger people. In such cases, bifurcation lesions help treat the blood clots to allow adequate blood flow to your heart. For instance, in October 2022, according to a report published by the World Health Organization (WHO), a Switzerland-based agency responsible for international public health, one in six people is expected to be 60 or older by the year 2030, in the entire world. By 2050, there will be 2.1 billion people worldwide who are 60 years old or older. The number of persons who are 80 years of age or older will increase by 426 million between 2020 and 2050 compared to the current population. Therefore, the increasing geriatric population will drive the bifurcation lesions market growth.

Bifurcation Lesions Market Driver: Elevated Healthcare Expenditure Fuels Growth In The Bifurcation Lesions Market

The increasing healthcare expenditure is expected to boost the growth of the bifurcation lesions market going forward. Healthcare infrastructure refers to all costs or outlays for medical care, preventative measures, public health initiatives, rehabilitation, community health activities, and health research. Higher healthcare spending allows healthcare facilities to invest in state-of-the-art equipment and technologies, including advanced interventional cardiology devices for treating bifurcation lesions. For instance, in March 2022, according to the 2021–2030 National Health Expenditure (NHE) report published by the Centers for Medicare & Medicaid Services, a US-based federal agency, it was estimated that between 2021 and 2030, national health spending is going to rise by an average of 5.1% every year, reaching almost $6.8 trillion. Additionally, it is anticipated that from 2021 to 2030, Medicare spending is going to rise at a 7.2% annual pace while Medicaid spending will rise at a 5.6% annual rate. Therefore, the increasing healthcare expenditure is driving the growth of the bifurcation lesions market.

Global Bifurcation Lesions Market Major Players

Major companies operating in the bifurcation lesions market include Boston Scientific Corporation, Terumo Medical Corporation, Spectranetics Corporation, Medtronic plc, Cardinal Health Inc., Cardinal Health Company, Abbott Laboratories, Biosensors International Group Ltd., B. Braun Melsungen AG, Cook Medical LLC, Cordis Corporation, Endologix Inc., W. L. Gore & Associates Inc., InspireMD Inc., Lombard Medical Technologies PLC, MicroPort Scientific Corporation, OrbusNeich Medical Company Limited, Biotronik SE & Co. KG, Cardionovum GmbH, Elixir Medical Corporation, Medinol Ltd., Meril Life Sciences Pvt. Ltd., MIV Therapeutics Inc., Natec Medical Ltd., Opto Circuits (India) Ltd., QualiMed Innovative Medizinprodukte GmbH, Sahajanand Medical Technologies Pvt. Ltd., Svelte Medical Systems Inc., Translumina GmbH, Vascular Concepts Limited, Vascular Solutions Inc., Veryan Medical Ltd., X-Cell Medical Inc., Zorion Medical Inc., Amaranth Medical Inc., Cardiomind Inc., Cardiva Medical Inc.

Global Bifurcation Lesions Market Trend: Advancements In Imaging And Procedure Devices

The advancement in devices used in imaging and procedures is a key trend that is gaining popularity in the bifurcation lesions market. Major companies operating in the market are concentrating their efforts on advancements in existing devices used in imaging and procedures. For instance, Advanced Bifurcation Systems (ABS), a clinical-stage medical device firm with a unique bifurcation stenting solution to standardize the treatment of all bifurcation lesions in coronary angioplasties, has a platform featuring the only modular self-aligning stent technology to evenly structure bifurcations. The ABS platform is a unique single system that reduces the need for repeat procedures and enables effective bifurcation stenting treatment.

Global Bifurcation Lesions Market Trend: Product Innovations In Bifurcation Lesions Market

Major companies operating in the bifurcation lesions market are developing innovative products such as drug-eluting coronary stent systems to meet larger customer bases, more sales, and increase revenue. A drug-eluting coronary stent system is a medical device used in interventional cardiology to treat coronary artery disease. For instance, in August 2023, Medtronic Plc, an Ireland-based medical device company, launched Onyx Frontier drug-eluting stent (DES), for the management of non-left main bifurcation lesions using the provisional stenting technique. One distinguishing characteristic of this product is its design enhancements, which encompass an inventive dual-layer balloon, reduced crossing profile, and heightened catheter flexibility. These improvements result in a 16% enhancement in deliverability compared to the prior-generation Resolute Onyx DES, all while maintaining the same level of radial strength. Aside from the improvements in the delivery system, Onyx Frontier provides an extensive range of sizes, accommodating patients with diameters ranging from 2.0mm to 5.0mm. Notably, its 4.50-5.00 mm sizes can be expanded to 6.00mm, catering specifically to the treatment of extra-large vessels, including those in the left main. Onyx Frontier inherits the same clinical data and indications as Resolute Onyx, including approval for treating bifurcation lesions, left main percutaneous coronary intervention (PCI), and a recommended one-month duration of dual antiplatelet therapy (DAPT) for high bleeding risk patients.

Bifurcation Lesions Market Merger And Acquisition: Boston Scientific Corporation Acquired Devoro Medical Inc.

In September 2021, Boston Scientific Corporation, a US-based biomedical/biotechnology engineering firm and manufacturer of medical devices used in interventional medical specialties, acquired Devoro Medical, Inc. for an undisclosed amount. Through this acquisition, Boston Scientific will focus on clot management and commercialization using the WOLF Thrombectomy Platform developed by Devoro Medical. Innovative non-console and lytic-free WOLF technology use finger-like prongs to extract and remove thrombi in the arterial and venous systems to target and quickly trap blood clots. This technology will enhance and broaden its selection of interventional strategies for thromboemboli, including the AngioJet Thrombectomy System and the EkoSonic Endovascular System (EKOS). Devoro Medical, Inc is a US-based developer of a medical device intended to restore blood flow.

Regional Outlook For The Global Bifurcation Lesions Market

North America was the largest region in the bifurcation lesions market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bifurcation lesions market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bifurcation lesions market report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The bifurcation lesions market includes revenues earned by proximal main branch (MB), distal MB and side branch (SB). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The bifurcation lesions market research report is one of a series of new reports from The Business Research Company that provides bifurcation lesions market statistics, including bifurcation lesions industry global market size, regional shares, competitors with a bifurcation lesions market share, detailed bifurcation lesions market segments, market trends and opportunities, and any further data you may need to thrive in the bifurcation lesions industry. This bifurcation lesions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Bifurcation Lesions Market Report Forecast And Analysis
Report AttributeDetails
Market Size Value In 2024 $2.7 billion
Revenue Forecast In 2033 $3.74 billion
Growth Rate CAGR of 8.5% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Types: One-Stent, Two-Stent
2) By Application: Coronary Vascular, Peripheral Vascular
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Boston Scientific Corporation; Terumo Medical Corporation; Spectranetics Corporation; Medtronic plc; Cardinal Health Inc.; Cardinal Health Company; Abbott Laboratories; Biosensors International Group Ltd.; B. Braun Melsungen AG; Cook Medical LLC; Cordis Corporation; Endologix Inc.; W. L. Gore & Associates Inc.; InspireMD Inc.; Lombard Medical Technologies PLC; MicroPort Scientific Corporation; OrbusNeich Medical Company Limited; Biotronik SE & Co. KG; Cardionovum GmbH; Elixir Medical Corporation; Medinol Ltd.; Meril Life Sciences Pvt. Ltd.; MIV Therapeutics Inc.; Natec Medical Ltd.; Opto Circuits (India) Ltd.; QualiMed Innovative Medizinprodukte GmbH; Sahajanand Medical Technologies Pvt. Ltd.; Svelte Medical Systems Inc.; Translumina GmbH; Vascular Concepts Limited; Vascular Solutions Inc.; Veryan Medical Ltd.; X-Cell Medical Inc.; Zorion Medical Inc.; Amaranth Medical Inc.; Cardiomind Inc.; Cardiva Medical Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Bifurcation Lesions Market Characteristics

    3. Bifurcation Lesions Market Trends And Strategies

    4. Bifurcation Lesions Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Bifurcation Lesions Market Size and Growth

    5.1. Global Bifurcation Lesions Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Bifurcation Lesions Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Bifurcation Lesions Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Bifurcation Lesions Market Segmentation

    6.1. Global Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    One-Stent

    Two-Stent

    6.2. Global Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Coronary Vascular

    Peripheral Vascular

    7. Bifurcation Lesions Market Regional And Country Analysis

    7.1. Global Bifurcation Lesions Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Bifurcation Lesions Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Bifurcation Lesions Market  

    8.1. Asia-Pacific Bifurcation Lesions Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Bifurcation Lesions Market  

    9.1. China Bifurcation Lesions Market Overview  

    9.2. China Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Bifurcation Lesions Market  

    10.1. India Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Bifurcation Lesions Market  

    11.1. Japan Bifurcation Lesions Market Overview  

    11.2. Japan Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Bifurcation Lesions Market  

    12.1. Australia Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Bifurcation Lesions Market  

    13.1. Indonesia Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Bifurcation Lesions Market  

    14.1. South Korea Bifurcation Lesions Market Overview  

    14.2. South Korea Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Bifurcation Lesions Market  

    15.1. Western Europe Bifurcation Lesions Market Overview

    15.2. Western Europe Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Bifurcation Lesions Market  

    16.1. UK Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Bifurcation Lesions Market  

    17.1. Germany Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Bifurcation Lesions Market  

    18.4. France Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.5. France Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Bifurcation Lesions Market  

    19.7. Italy Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.8. Italy Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Bifurcation Lesions Market  

    20.10. Spain Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.11. Spain Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Bifurcation Lesions Market  

    21.1. Eastern Europe Bifurcation Lesions Market Overview

    21.2. Eastern Europe Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Bifurcation Lesions Market  

    22.1. Russia Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Bifurcation Lesions Market  

    23.1. North America Bifurcation Lesions Market Overview

    23.2. North America Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Bifurcation Lesions Market  

    24.1. USA Bifurcation Lesions Market Overview

    24.2. USA Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Bifurcation Lesions Market  

    25.1. Canada Bifurcation Lesions Market Overview

    25.2. Canada Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Bifurcation Lesions Market  

    26.1. South America Bifurcation Lesions Market Overview

    26.2. South America Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Bifurcation Lesions Market  

    27.1. Brazil Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Bifurcation Lesions Market  

    28.1. Middle East Bifurcation Lesions Market Overview

    28.2. Middle East Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Bifurcation Lesions Market  

    29.1. Africa Bifurcation Lesions Market Overview

    29.2. Africa Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Bifurcation Lesions Market Competitive Landscape And Company Profiles

    30.1. Bifurcation Lesions Market Competitive Landscape

    30.2. Bifurcation Lesions Market Company Profiles

    30.2.1. Boston Scientific Corporation

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Terumo Medical Corporation

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Spectranetics Corporation

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Medtronic plc

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Cardinal Health Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Bifurcation Lesions Market Competitive Benchmarking

    32. Global Bifurcation Lesions Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Bifurcation Lesions Market

    34. Bifurcation Lesions Market Future Outlook and Potential Analysis

    34.1 Bifurcation Lesions Market In 2028 - Countries Offering Most New Opportunities

    34.2 Bifurcation Lesions Market In 2028 - Segments Offering Most New Opportunities

    34.3 Bifurcation Lesions Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Bifurcation Lesions Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Bifurcation Lesions Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Asia-Pacific, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: China, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: China, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: India, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: India, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: Japan, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: Japan, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: Australia, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: Australia, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Indonesia, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Indonesia, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: South Korea, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: South Korea, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Western Europe, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Western Europe, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: UK, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: UK, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Germany, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Germany, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: France, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: France, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Italy, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Italy, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Spain, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Spain, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: Eastern Europe, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: Eastern Europe, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Russia, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Russia, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: North America, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: North America, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: USA, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: USA, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Canada, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Canada, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: South America, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: South America, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Brazil, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Brazil, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Middle East, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Middle East, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Africa, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Africa, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Boston Scientific Corporation Financial Performance
  • Table 52: Terumo Medical Corporation Financial Performance
  • Table 53: Spectranetics Corporation Financial Performance
  • Table 54: Medtronic plc Financial Performance
  • Table 55: Cardinal Health Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Bifurcation Lesions Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Bifurcation Lesions Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Asia-Pacific, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: China, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: China, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: India, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: India, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: Japan, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: Japan, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: Australia, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: Australia, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Indonesia, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Indonesia, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: South Korea, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: South Korea, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Western Europe, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Western Europe, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: UK, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: UK, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Germany, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Germany, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: France, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: France, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Italy, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Italy, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Spain, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Spain, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: Eastern Europe, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: Eastern Europe, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Russia, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Russia, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: North America, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: North America, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: USA, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: USA, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Canada, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Canada, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: South America, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: South America, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Brazil, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Brazil, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Middle East, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Middle East, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Africa, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Africa, Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Boston Scientific Corporation Financial Performance
  • Figure 52: Terumo Medical Corporation Financial Performance
  • Figure 53: Spectranetics Corporation Financial Performance
  • Figure 54: Medtronic plc Financial Performance
  • Figure 55: Cardinal Health Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the bifurcation lesions market?

Bifurcation lesions refer to a coronary artery constriction that occurs next to or involves the origin of a vital side branch one does not want to lose. It occurs when plaque deposits accumulate, and the artery becomes too small for adequate blood flow to your heart. For further insights on the bifurcation lesions market, request a sample here

How will the bifurcation lesions market drivers and restraints affect the bifurcation lesions market dynamics? What forces will shape the bifurcation lesions industry going forward?

The bifurcation lesions market major growth driver - Rising Geriatric Population Fuels Growth In The Bifurcation Lesions Market. For further insights on the bifurcation lesions market, request a sample here

What is the forecast market size or the forecast market value of the bifurcation lesions market?

The bifurcation lesions market size has grown strongly in recent years. It will grow from $2.47 billion in 2023 to $2.7 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rise in prevalence of coronary artery diseases, rise in geriatric population, rise in healthcare expenditure, economic growth. The bifurcation lesions market size is expected to see strong growth in the next few years. It will grow to $3.74 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing demand for minimally invasive surgeries, expansion of healthcare infrastructure and facilities, increasing prevalence of cardiovascular diseases, government healthcare policies. Major trends in the forecast period include patient-centric approaches, bioresorbable stents, integration of ai and machine learning, cross-specialty collaboration. For further insights on the bifurcation lesions market, request a sample here

How is the bifurcation lesions market segmented?

The bifurcation lesions market is segmented
1) By Types: One-Stent, Two-Stent
2) By Application: Coronary Vascular, Peripheral VascularFor further insights on the bifurcation lesions market,
request a sample here

Which region has the largest share of the bifurcation lesions market? What are the other regions covered in the report?

North America was the largest region in the bifurcation lesions market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bifurcation lesions market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on the bifurcation lesions market, request a sample here.

Who are the major players in the bifurcation lesions market?

Major companies operating in the bifurcation lesions market include Boston Scientific Corporation, Terumo Medical Corporation, Spectranetics Corporation, Medtronic plc, Cardinal Health Inc., Cardinal Health Company, Abbott Laboratories, Biosensors International Group Ltd., B. Braun Melsungen AG, Cook Medical LLC, Cordis Corporation, Endologix Inc., W. L. Gore & Associates Inc., InspireMD Inc., Lombard Medical Technologies PLC, MicroPort Scientific Corporation, OrbusNeich Medical Company Limited, Biotronik SE & Co. KG, Cardionovum GmbH, Elixir Medical Corporation, Medinol Ltd., Meril Life Sciences Pvt. Ltd., MIV Therapeutics Inc., Natec Medical Ltd., Opto Circuits (India) Ltd., QualiMed Innovative Medizinprodukte GmbH, Sahajanand Medical Technologies Pvt. Ltd., Svelte Medical Systems Inc., Translumina GmbH, Vascular Concepts Limited, Vascular Solutions Inc., Veryan Medical Ltd., X-Cell Medical Inc., Zorion Medical Inc., Amaranth Medical Inc., Cardiomind Inc., Cardiva Medical Inc. For further insights on the bifurcation lesions market, request a sample here.

What are the key trends in the bifurcation lesions market?

Major trend in the bifurcation lesions market - Advancements In Imaging And Procedure Devices. For further insights on the bifurcation lesions market, request a sample here.

What are the major opportunities in the bifurcation lesions market? What are the strategies for the bifurcation lesions market?

For detailed insights on the major opportunities and strategies in the bifurcation lesions market, request a sample here.

How does the bifurcation lesions market relate to the overall economy and other similar markets?

For detailed insights on bifurcation lesions market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the bifurcation lesions industry?

For detailed insights on the mergers and acquisitions in the bifurcation lesions industry, request a sample here.

What are the key dynamics influencing the bifurcation lesions market growth? SWOT analysis of the bifurcation lesions market.

For detailed insights on the key dynamics influencing the bifurcation lesions market growth and SWOT analysis of the bifurcation lesions industry, request a sample here.